PolyOne Acquires Spanish Colorants Producer
PolyOne Corporation announced that it has completed the funding of its December 19, 2002 acquisition of Transformacion de Pigmentos y Colorantes, S.A. (TRANSCOLOR), a large color concentrates producer operating near Pamplona in northern Spain.
TRANSCOLOR, with annual revenues of approximately $36 million (USD), is an ISO 9000-accredited, market-leading producer of color concentrates, with special emphasis on black and white products.
"TRANSCOLOR enhances PolyOne's product portfolio and provides a stronger platform for the delivery of our color and additive concentrates to customers in Spain and Portugal," said Bernard Baert, vice president of international operations for PolyOne. "In TRANSCOLOR, we have acquired an excellent company with a fine reputation among its customers, and we feel very positive about working with its skilled management and sales team."
The existing TRANSCOLOR management team, which will remain in place, has been integrated into PolyOne's European Color & Additives division.
PolyOne has already moved some production from its Saint-Ouen L'Aumone site near Paris to TRANSCOLOR, freeing capacity and allowing the French plant to focus on the production of color and additive systems for local customers.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
